Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Campbell

Physical Medicine & Rehabilitation Lander, WY Medical Doctor

NPI 1992936710 CMS profile 733605

329 Main St, Lander, WY 82520

Open in the dashboard

General payments

$10,318

237 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Campbell of Lander, WY is reported in the CMS Open Payments database as having received $10,318 across 237 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $858 22
2024 General $2,383 55
2023 General $1,812 51
2022 General $866 29
2021 General $297 15
2020 General $2,644 33
2019 General $1,458 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Campbell
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Robert Campbell were reported at $858. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Robert Campbell Physical Medicine & Rehabilitation median Middle half National median
2019 $1,458 $133 $45–$390 $163
2020 $2,644 $88 $29–$272 $114
2021 $297 $116 $33–$360 $132
2022 $866 $123 $40–$378 $149
2023 $1,812 $131 $43–$396 $160
2024 $2,383 $141 $45–$409 $164
2025 $858 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $10,117 228 payments
  2. SI-BONE, Inc. $52 1 payment
  3. AbbVie, Inc. $43 2 payments
  4. Merz North America, Inc. $37 2 payments
  5. Biohaven Pharmaceutical Holding Company Ltd. $27 1 payment
  6. Bioventus LLC $24 2 payments
  7. Saluda Medical Americas, Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,559 221 payments
  2. Travel and Lodging $3,668 14 payments
  3. Education $91 2 payments
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER Pain Management $3,169 19 payments
  2. WaveWriter Alpha Prime 16 $2,646 51 payments
  3. GENERAL PAIN MANAGEMENT $553 30 payments
  4. GENERAL - PAIN MANAGEMENT Pain Management $434 19 payments
  5. General - Pain Management General - Pain Management_NMD $398 15 payments
  6. Spectra WaveWriter Spectra WaveWriter_NMD $281 8 payments
  7. Vercise $185 4 payments
  8. General - Pain Management General Pain Management $140 7 payments
  9. Patient Trial Kit $138 3 payments
  10. Clik X $128 2 payments
  11. Other $893 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

32

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$67

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

0%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tramadol Hcl Generic 13 $51
Diazepam Generic 19 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$168,738

Of which drugs: $21,265

Medicare patients

288

Average age 69

Services billed

7,532

186 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 66%
Depression 32%
Diabetes 26%
COPD 23%
Ischemic heart disease 18%
Chronic kidney disease 15%
Osteoporosis 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 228 2,312 $1,747
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 114 360 $38
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 18 21 $2

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

237 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record